Agency Forms Undergoing Paperwork Reduction Acct Review, 65359 [2016-22866]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 184 / Thursday, September 22, 2016 / Notices
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than October 17,
2016.
A. Federal Reserve Bank of Cleveland
(Nadine Wallman, Vice President) 1455
East Sixth Street, Cleveland, Ohio
44101–2566. Comments can also be sent
electronically to
Comments.applications@clev.frb.org:
1. F.N.B. Corporation, Pittsburgh,
Pennsylvania; to acquire Yadkin
Financial Corporation, Raleigh, North
Carolina, and thereby acquire Yadkin
Bank, Statesville, North Carolina,
Board of Governors of the Federal Reserve
System, September 19, 2016.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2016–22847 Filed 9–21–16; 8:45 am]
BILLING CODE 6210–01–P
Centers for Disease Control and
Prevention
[30Day–16–0997]
Agency Forms Undergoing Paperwork
Reduction Acct Review
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period;
withdrawal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the
withdrawal of the notice published
under the same title on August 25, 2016
for public comment.
DATES: Effective September 22, 2016.
FOR FURTHER INFORMATION CONTACT:
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: On August
25, 2016 CDC published a notice in the
Federal Register titled ‘‘Agency Forms
Undergoing Paperwork Reduction Act
Review’’ (Vol. 81, No. 165 FR Doc.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:58 Sep 21, 2016
[FR Doc. 2016–22866 Filed 9–21–16; 8:45 am]
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
BILLING CODE 4163–18–P
SUPPLEMENTARY INFORMATION:
2016–20333, Pages 58511–58512). This
notice was published prematurely and
inadvertently. The notice is being
withdrawn immediately for public
comment. A new notice will be
published at a later date for public
comment.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–0001]
Technical Electronic Product Radiation
Safety Standards Committee; Notice of
Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Technical Electronic
Product Radiation Safety Standards
Committee. The general function of the
committee is to provide advice and
recommendations to the Agency on
FDA’s regulatory issues. The meeting
will be open to the public.
DATES: The meeting will be held on
October 25, 2016, from 8:30 a.m. to 5
p.m. and October 26, 2016, from 8:30
a.m. to 5 p.m.
ADDRESSES: Gaithersburg Holiday Inn,
Ballroom, Two Montgomery Village
Ave., Gaithersburg, MD 20879. The
hotel’s telephone number is 301–948–
8900. Answers to commonly asked
questions including information
regarding special accommodations due
to a disability, visitor parking, and
transportation may be accessed at:
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
FOR FURTHER INFORMATION CONTACT: Sara
J. Anderson, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 1643, Silver Spring,
MD 20993–0002, sara.anderson@
fda.hhs.gov, 301–796–7047, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 238001
65359
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Agenda: The general function of the
committee is to provide advice and
recommendations to the Agency on the
technical feasibility, reasonableness,
and practicability of performance
standards for electronic products to
control the emission of radiation from
such products, and may recommend
electronic product radiation safety
standards to the Agency for
consideration.
On October 25, 2016, the committee
will discuss and make
recommendations regarding possible
FDA performance standards for the
following topics: Radiofrequency (RF)
radiation products, such as microwave
ovens and wireless power transfer; laser
products, including an update to
amendments to the laser rule, light
detection and ranging (LIDAR), laser
data (Light Fidelity-LiFi)/energy
transfer, illumination applications and
infrared applications; sunlamp products
including an update on the performance
standards amendments; and noncoherent light sources (e.g., LEDs and
UVC lamps) including new initiatives.
On October 26, 2016, the committee
will discuss and make
recommendations regarding possible
FDA performance standards for the
following topics: International
Electrotechnical Commission (IEC)
standards versus performance standards
for medical devices; computed
tomography (CT); radiography and
fluoroscopy; diagnostic and therapeutic
ultrasound; and radiation therapy.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 81, Number 184 (Thursday, September 22, 2016)]
[Notices]
[Page 65359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22866]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0997]
Agency Forms Undergoing Paperwork Reduction Acct Review
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the withdrawal
of the notice published under the same title on August 25, 2016 for
public comment.
DATES: Effective September 22, 2016.
FOR FURTHER INFORMATION CONTACT: Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: On August 25, 2016 CDC published a notice in
the Federal Register titled ``Agency Forms Undergoing Paperwork
Reduction Act Review'' (Vol. 81, No. 165 FR Doc. 2016-20333, Pages
58511-58512). This notice was published prematurely and inadvertently.
The notice is being withdrawn immediately for public comment. A new
notice will be published at a later date for public comment.
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-22866 Filed 9-21-16; 8:45 am]
BILLING CODE 4163-18-P
